search
Back to results

Angiogenesis With Positron Emission Tomography (PET) Tracer Uptake (angiogenesis)

Primary Purpose

Angiogenesis, Non-Small Cell Lung Cancer

Status
Completed
Phase
Locations
Japan
Study Type
Observational
Intervention
Sponsored by
Gunma University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an observational trial for Angiogenesis focused on measuring Fluorine-18-α-methyltyrosine,, Positron emission tomography,, Fluorine-18-fluorodeoxyglucose,, Lung cancer,, Angiogenesis, The median VEGF rate was 45% (range, 10-78%)., High expression was seen in 30 patients (81%, 30/37)., VEGF expression was statistically associated with progressively growing microvessel count.

Eligibility Criteria

undefined - undefined (Child, Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Patients who underwent a thoracotomy within 4 weeks after 18F-FMT PET and 18F-FDG PET study
  • Histology is non-small cell lung cancer

Exclusion Criteria:

  • Patient who received neoadjuvant chemotherapy or radiotherapy before surgery
  • Patients who have insulin-dependent diabetes

Sites / Locations

  • Gunma University Graduate School of Medicine

Arms of the Study

Arm 1

Arm 2

Arm Type

Arm Label

I

Nuclear

Arm Description

L-[3-18F]-α-methyltyrosine (18F-FMT) is an amino-acid tracer for PET. We have conducted a clinicopathologic study to elucidate the correlation of angiogenesis with 18F-FMT and 18F-FDG uptake in the patients with non-small cell lung cancer

Outcomes

Primary Outcome Measures

Secondary Outcome Measures

Full Information

First Posted
April 30, 2008
Last Updated
May 2, 2008
Sponsor
Gunma University
Collaborators
J~pharma
search

1. Study Identification

Unique Protocol Identification Number
NCT00671242
Brief Title
Angiogenesis With Positron Emission Tomography (PET) Tracer Uptake
Acronym
angiogenesis
Official Title
Correlation of Angiogenesis With 18F-FMT and 18F-FDG Uptake in Non-Small Cell Lung Cancer
Study Type
Observational

2. Study Status

Record Verification Date
January 2008
Overall Recruitment Status
Completed
Study Start Date
undefined (undefined)
Primary Completion Date
undefined (undefined)
Study Completion Date
undefined (undefined)

3. Sponsor/Collaborators

Name of the Sponsor
Gunma University
Collaborators
J~pharma

4. Oversight

Data Monitoring Committee
Yes

5. Study Description

Brief Summary
Purpose: L-[3-18F]-α-methyltyrosine (18F-FMT) is an amino-acid tracer for PET. We have conducted a clinicopathologic study to elucidate the correlation of angiogenesis with 18F-FMT and 18F-FDG uptake in the patients with non-small cell lung cancer (NSCLC). Method: Thirty-seven NSCLC patients were enrolled in this study, and a pair of PET study with 18F-FMT and 18F-FDG was performed. Uptake of PET tracers was evaluated with standardized uptake value. VEGF, CD31, CD34, LAT1 and Ki-67 labeling index of the resected tumors were analyzed by immunohistochemical staining, and correlated with the clinicopathologic variables and the uptake of PET tracers.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Angiogenesis, Non-Small Cell Lung Cancer
Keywords
Fluorine-18-α-methyltyrosine,, Positron emission tomography,, Fluorine-18-fluorodeoxyglucose,, Lung cancer,, Angiogenesis, The median VEGF rate was 45% (range, 10-78%)., High expression was seen in 30 patients (81%, 30/37)., VEGF expression was statistically associated with progressively growing microvessel count.

7. Study Design

8. Arms, Groups, and Interventions

Arm Title
I
Arm Description
L-[3-18F]-α-methyltyrosine (18F-FMT) is an amino-acid tracer for PET. We have conducted a clinicopathologic study to elucidate the correlation of angiogenesis with 18F-FMT and 18F-FDG uptake in the patients with non-small cell lung cancer
Arm Title
Nuclear

10. Eligibility

Sex
All
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Patients who underwent a thoracotomy within 4 weeks after 18F-FMT PET and 18F-FDG PET study Histology is non-small cell lung cancer Exclusion Criteria: Patient who received neoadjuvant chemotherapy or radiotherapy before surgery Patients who have insulin-dependent diabetes
Facility Information:
Facility Name
Gunma University Graduate School of Medicine
City
showa-machi, Maebashi, Gunma
ZIP/Postal Code
371-8511
Country
Japan

12. IPD Sharing Statement

Citations:
PubMed Identifier
19141127
Citation
Kaira K, Oriuchi N, Shimizu K, Ishikita T, Higuchi T, Imai H, Yanagitani N, Sunaga N, Hisada T, Ishizuka T, Kanai Y, Endou H, Nakajima T, Endo K, Mori M. Correlation of angiogenesis with 18F-FMT and 18F-FDG uptake in non-small cell lung cancer. Cancer Sci. 2009 Apr;100(4):753-8. doi: 10.1111/j.1349-7006.2008.01077.x. Epub 2009 Jan 12.
Results Reference
derived

Learn more about this trial

Angiogenesis With Positron Emission Tomography (PET) Tracer Uptake

We'll reach out to this number within 24 hrs